Single-use duodenoscope market seen hitting $1.17 billion by 2030

The Business Research Company says the global single-use duodenoscope market is expected to grow from $0.68 billion in 2026 to $1.17 billion by 2030, driven by infection-control concerns, rising ERCP volumes and broader adoption of disposable medical devices. North America led the market in 2025, while Europe is forecast to grow fastest through 2030.

Why it matters: - Single-use duodenoscopes aim to reduce infection risk and cross-contamination in endoscopic procedures. - The market’s growth reflects continued pressure on hospitals to limit healthcare-associated infections and move toward disposable devices. - The category is tied closely to ERCP procedures used to diagnose and treat bile duct and pancreatic disorders.

What happened: - The Business Research Company projected the single-use duodenoscope market will grow from $0.59 billion in 2025 to $0.68 billion in 2026. - The company forecasts the market will reach $1.17 billion by 2030. - The report cited a 2026–2035 outlook and identified the market as expanding at a 14.3% CAGR in the historical period and 14.6% through 2030. - The company released its market report on June 26, 2026, from London. - The report is available as a full market report, and a free sample is also offered.

The details: - Single-use duodenoscopes are sterile, disposable devices used for procedures in the duodenum. - The devices do not require cleaning or sterilization after each use. - The scopes are mainly used during endoscopic retrograde cholangiopancreatography, or ERCP. - The devices are designed to diagnose and treat conditions affecting the bile ducts and pancreas. - The report says the market’s historical growth has been supported by higher rates of bile duct and pancreatic disorders. - The report also points to wider ERCP use, more minimally invasive surgery, improved hospital endoscopy facilities and greater concern about hospital-acquired infections from reusable scopes. - Future growth is expected to come from stronger demand for infection prevention, higher healthcare spending, more gastroenterology procedures, better disposable imaging technology, growth in ambulatory surgery centers and outpatient care, and stricter regulations on cross-contamination. - The report says broader use of single-use scopes, more sterile disposable ERCP devices, expansion of outpatient endoscopy and tighter infection-control rules are key trends.

Between the lines: - The market forecast suggests infection control is becoming a purchasing priority, not just a clinical preference. - Disposable scopes may gain share as hospitals and outpatient centers try to reduce reprocessing risk and simplify workflow. - The report frames regulatory pressure and infection data as reinforcing the shift away from reusable instruments. - In September 2024, the UK Health Security Agency reported hospital-onset healthcare-associated E. coli infections rose from 6,525 cases in 2022 to 7,881 in 2023. - Data from the UK-based IBD Registry showed that by December 2023, more than 5,300 people had been diagnosed with inflammatory bowel disease, up by more than 3,000 from 2022.

What's next: - North America held the largest share of the market in 2025. - Europe is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel forecasting dashboards, market hotspot infographics and updated trend analysis.

The bottom line: - Single-use duodenoscopes are moving from a niche infection-control option toward a larger global market as hospitals seek safer ERCP tools and regulators push harder on contamination risks.